Search News + Media

Tufts Medical Center announced today that it has become the first center in New England to use the drug Jelmyto (UroGen Pharma, Inc.) for treatment of upper tract urothelial cancer (UTUC), a malignancy found in the kidney lining or the ureter, the thin tube connecting the bladder to the kidneys.

Petra was referred to Tufts MC by her local PCP after they discovered a mass on her kidney. The Tufts MC team was able to get her back on her toes.